E nā mea kūʻai mahalo:
Ke holomua nei ka maʻi maʻi SARS-CoV-2, ke hoʻomau nei nā mutations hou a me nā ʻano like ʻole o ka maʻi, ʻaʻole ia he atypical. I kēia manawa, aia ka manaʻo i kahi ʻano like ʻole mai ʻEnelani a me ʻApelika Hema me ka piʻi ʻana o ka infectivity, a ʻo ka nīnau inā pahanā hoʻokolohua antigen wikiwikihiki no hoi ke ike i keia mutation.
Wahi a kā mākou noiʻi ʻana, ua loaʻa kekahi mau hoʻololi pūnaewele o ka protein spike ma nā kūlana o N501Y, E484K, K417N no SA mutant strain 501Y.V2, a me N501Y, P681H, 69-70 no UK mutant strain b.1.1.7 (Mai mai. Guangdong Provincial Center for Disease Control and Prevention). No ka mea, ʻo ka pūnaewele ʻike o nā mea maka i hoʻohana ʻia i kā mākou hoʻāʻo antigen ʻo ia ka protein nucleocapsid ʻokoʻa mai nā pūnaewele mutation, Aia kēia protein ma luna o ka ʻili o ka maʻi a koi ʻia no ka maʻi e komo i ka cell host.
Eia nō naʻe, hoʻāʻo ka Testsealabs COVID-19 Antigen Rapid Test i kahi protein hou o ka maʻi, ka mea i kapa ʻia ʻo nucleocapsid protein, aia i loko o ka maʻi a ʻaʻole hoʻololi ʻia e ka mutation. No laila, e like me ke kūlana ʻepekema o kēia manawa, hiki ke ʻike ʻia kēia ʻano e ka Testsealabs COVID-19 Antigen Rapid Test.
I kēia manawa, e kamaʻilio koke mākou i nā mea hou e pili ana iā SARS-CoV-2Mea Ho'āʻo Rapid Antigen. Eia kekahi, e hoʻomau mākou i kā mākou mau hana e hoʻokō i nā kiʻekiʻenā kūlana hoʻokele maikaʻi a mālama i kahi ʻōnaehana hoʻokele kūlana kiʻekiʻe e hōʻoia i ka ʻoluʻolu o ka mea kūʻai aku a me ka palekana o ka huahana. Inā he mau nīnau kāu, e ʻoluʻolu e kelepona i kā mākou mea kūʻai aku.
ʻO Hangzhou Testsea Biotechnology Co., Ltd
Ka manawa hoʻouna: Jan-21-2021